Amoeba SA
Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopath… Read more
Amoeba SA (ALMIB) - Total Assets
Latest total assets as of June 2025: €6.37 Million EUR
Based on the latest financial reports, Amoeba SA (ALMIB) holds total assets worth €6.37 Million EUR as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Amoeba SA - Total Assets Trend (2011–2024)
This chart illustrates how Amoeba SA’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Amoeba SA - Asset Composition Analysis
Current Asset Composition (December 2024)
Amoeba SA's total assets of €6.37 Million consist of 38.6% current assets and 61.4% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 8.1% |
| Accounts Receivable | €61.47K | 1.1% |
| Inventory | €257.06K | 4.6% |
| Property, Plant & Equipment | €2.40 Million | 42.5% |
| Intangible Assets | €967.47K | 17.1% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2011–2024)
This chart illustrates how Amoeba SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Amoeba SA's current assets represent 38.6% of total assets in 2024, a decrease from 41.7% in 2011.
- Cash Position: Cash and equivalents constituted 8.1% of total assets in 2024, down from 27.5% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 17.0% of total assets, a decrease from 33.0% in 2011.
- Asset Diversification: The largest asset category is property, plant & equipment at 42.5% of total assets.
Amoeba SA Competitors by Total Assets
Key competitors of Amoeba SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Nanjing Red Sun Co Ltd
SHE:000525
|
China | CN¥6.84 Billion |
|
ADAMA Ltd
SHE:000553
|
China | CN¥49.93 Billion |
|
Grand Industrial Holding Co Ltd
SHE:000626
|
China | CN¥8.43 Billion |
|
Qinghai Salt Lake Industry Co.Ltd
SHE:000792
|
China | CN¥50.97 Billion |
|
Sichuan Meifeng Chemical Industry Co Ltd
SHE:000731
|
China | CN¥5.17 Billion |
|
Asia Potash International Investment Guangzhou Co Ltd
SHE:000893
|
China | CN¥19.38 Billion |
|
Hubei Xinyangfeng Fertilizer Co Ltd
SHE:000902
|
China | CN¥19.75 Billion |
|
Sichuan Lutianhua Co Ltd
SHE:000912
|
China | CN¥9.46 Billion |
Amoeba SA - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Amoeba SA generates 0.11x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Amoeba SA is currently not profitable relative to its asset base.
Amoeba SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.28 | 0.33 | 0.55 |
| Quick Ratio | 0.25 | 0.30 | 0.55 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-6.38 Million | € -5.22 Million | € -4.25 Million |
Amoeba SA - Advanced Valuation Insights
This section examines the relationship between Amoeba SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.44 |
| Latest Market Cap to Assets Ratio | 10.31 |
| Asset Growth Rate (YoY) | -10.1% |
| Total Assets | €5.65 Million |
| Market Capitalization | $58.28 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Amoeba SA's assets at a significant premium ( 10.31x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Amoeba SA's assets decreased by 10.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Amoeba SA (2011–2024)
The table below shows the annual total assets of Amoeba SA from 2011 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €5.65 Million | -10.11% |
| 2023-12-31 | €6.29 Million | -49.27% |
| 2022-12-31 | €12.39 Million | -14.55% |
| 2021-12-31 | €14.50 Million | +11.00% |
| 2020-12-31 | €13.06 Million | -5.61% |
| 2019-12-31 | €13.84 Million | +99317.53% |
| 2018-12-31 | €13.92K | -35.49% |
| 2017-12-31 | €21.58K | -7.43% |
| 2016-12-31 | €23.31K | +64.93% |
| 2015-12-31 | €14.13K | -99.75% |
| 2014-12-31 | €5.55 Million | +148.31% |
| 2013-12-31 | €2.24 Million | +30.13% |
| 2012-12-31 | €1.72 Million | +36.50% |
| 2011-12-31 | €1.26 Million | -- |